The US neurostimulation technology market will grow nearly 46% over the next five years, driven by the introduction of more effective implantable neurostimulation devices and increasing awareness and acceptance of these technologies among patients and physicians, according to a new report from Medtech Insight
. In 2014, the total US neurostimulation market was worth about $2.26 billion, but the cost of clinical trials and reimbursement hurdles, especially for less-established technologies and indications, has left...